Cargando…

Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer

Ovarian high grade serous carcinoma (HGSC) is a lethal form of ovarian cancer (OVCA). In most cases it is detected at late stages as the symptoms are non-specific during early stages. Emerging information suggests that the oviductal fimbria is a site of origin of ovarian HGSC. Currently available te...

Descripción completa

Detalles Bibliográficos
Autores principales: Paris, Elizabeth A., Bahr, Janice M., Bitterman, Pincas, Basu, Sanjib, Abramowicz, Jacques S., Barua, Animesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315513/
https://www.ncbi.nlm.nih.gov/pubmed/34314463
http://dx.doi.org/10.1371/journal.pone.0255007
_version_ 1783729733854298112
author Paris, Elizabeth A.
Bahr, Janice M.
Bitterman, Pincas
Basu, Sanjib
Abramowicz, Jacques S.
Barua, Animesh
author_facet Paris, Elizabeth A.
Bahr, Janice M.
Bitterman, Pincas
Basu, Sanjib
Abramowicz, Jacques S.
Barua, Animesh
author_sort Paris, Elizabeth A.
collection PubMed
description Ovarian high grade serous carcinoma (HGSC) is a lethal form of ovarian cancer (OVCA). In most cases it is detected at late stages as the symptoms are non-specific during early stages. Emerging information suggests that the oviductal fimbria is a site of origin of ovarian HGSC. Currently available tests cannot detect ovarian HGSC at early stage. The lack of a preclinical model with oviductal fimbria that develops spontaneous ovarian HGSC is a significant barrier to developing an early detection test for this disease. The goal of this study was to examine if the oviductal fimbria in hens is a site of origin of HGSC and whether it expresses several putative markers expressed in ovarian HGSC in patients. A total of 135 laying hens (4 years old) were selected from a flock using transvaginal ultrasound (TVUS) imaging, followed by euthanasia and gross examination for the presence of solid masses and ascites. Histological types of carcinomas were determined by hematoxylin and eosin staining. Expression of WT-1, mutant p53, CA-125, PAX2 and Ki67 in normal or malignant fimbriae or ovaries were examined using immunohistochemistry, immunoblotting and gene expression assays. This study detected tumors in oviductal fimbriae in hens and routine staining revealed ovarian HGSC-like microscopic features in these tumors. These tumors showed similarities to ovarian HGSC in patients in expressing several markers. Compared with normal fimbriae, intensities of expression of WT-1, mutant p53, CA-125, and Ki67 were significantly (P<0.05) higher in fimbrial tumors. In contrast, expression of PAX2 decreased gradually as the tumor progressed to late stages. The patterns of expression of these markers were similar to those in ovarian HGSC patients. Thus, tumors of the oviductal fimbria in hens may offer a preclinical model to study different aspects of spontaneous ovarian HGSC in women including its early detection.
format Online
Article
Text
id pubmed-8315513
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83155132021-07-31 Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer Paris, Elizabeth A. Bahr, Janice M. Bitterman, Pincas Basu, Sanjib Abramowicz, Jacques S. Barua, Animesh PLoS One Research Article Ovarian high grade serous carcinoma (HGSC) is a lethal form of ovarian cancer (OVCA). In most cases it is detected at late stages as the symptoms are non-specific during early stages. Emerging information suggests that the oviductal fimbria is a site of origin of ovarian HGSC. Currently available tests cannot detect ovarian HGSC at early stage. The lack of a preclinical model with oviductal fimbria that develops spontaneous ovarian HGSC is a significant barrier to developing an early detection test for this disease. The goal of this study was to examine if the oviductal fimbria in hens is a site of origin of HGSC and whether it expresses several putative markers expressed in ovarian HGSC in patients. A total of 135 laying hens (4 years old) were selected from a flock using transvaginal ultrasound (TVUS) imaging, followed by euthanasia and gross examination for the presence of solid masses and ascites. Histological types of carcinomas were determined by hematoxylin and eosin staining. Expression of WT-1, mutant p53, CA-125, PAX2 and Ki67 in normal or malignant fimbriae or ovaries were examined using immunohistochemistry, immunoblotting and gene expression assays. This study detected tumors in oviductal fimbriae in hens and routine staining revealed ovarian HGSC-like microscopic features in these tumors. These tumors showed similarities to ovarian HGSC in patients in expressing several markers. Compared with normal fimbriae, intensities of expression of WT-1, mutant p53, CA-125, and Ki67 were significantly (P<0.05) higher in fimbrial tumors. In contrast, expression of PAX2 decreased gradually as the tumor progressed to late stages. The patterns of expression of these markers were similar to those in ovarian HGSC patients. Thus, tumors of the oviductal fimbria in hens may offer a preclinical model to study different aspects of spontaneous ovarian HGSC in women including its early detection. Public Library of Science 2021-07-27 /pmc/articles/PMC8315513/ /pubmed/34314463 http://dx.doi.org/10.1371/journal.pone.0255007 Text en © 2021 Paris et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Paris, Elizabeth A.
Bahr, Janice M.
Bitterman, Pincas
Basu, Sanjib
Abramowicz, Jacques S.
Barua, Animesh
Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer
title Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer
title_full Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer
title_fullStr Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer
title_full_unstemmed Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer
title_short Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer
title_sort incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315513/
https://www.ncbi.nlm.nih.gov/pubmed/34314463
http://dx.doi.org/10.1371/journal.pone.0255007
work_keys_str_mv AT pariselizabetha incidenceofmalignanttransformationintheoviductalfimbriainlayinghensapreclinicalmodelofspontaneousovariancancer
AT bahrjanicem incidenceofmalignanttransformationintheoviductalfimbriainlayinghensapreclinicalmodelofspontaneousovariancancer
AT bittermanpincas incidenceofmalignanttransformationintheoviductalfimbriainlayinghensapreclinicalmodelofspontaneousovariancancer
AT basusanjib incidenceofmalignanttransformationintheoviductalfimbriainlayinghensapreclinicalmodelofspontaneousovariancancer
AT abramowiczjacquess incidenceofmalignanttransformationintheoviductalfimbriainlayinghensapreclinicalmodelofspontaneousovariancancer
AT baruaanimesh incidenceofmalignanttransformationintheoviductalfimbriainlayinghensapreclinicalmodelofspontaneousovariancancer